InvestorsHub Logo
Followers 253
Posts 17890
Boards Moderated 0
Alias Born 01/19/2006

Re: None

Wednesday, 06/08/2016 3:34:22 PM

Wednesday, June 08, 2016 3:34:22 PM

Post# of 1050
We attended ASCO 2016 and visited numerous companies' booths and posters, including the large JNJ/Janssen site. I understand that JNJ is participating in the following project discussed by Vice President Biden in his remarks near the close of ASCO this past Monday....take some time, about 1/2 hour, for an introduction to a massive IT and R&D effort to find better ways to attack cancer worldwide.

We found the remarks of Vice President Biden at ASCO to be educational from a bigger picture perspective. My wife and I saw and heard the remarks from the vantage point of an overflow auditorium. Estimated attendance of scientists and M.D.s: 37k.

http://am.asco.org/virtual-meeting-on-demand/presentation/biden-info

A Washington Post article highlighted the same earlier in the morning:

https://www.washingtonpost.com/national/health-science/biden-to-unveil-launch-of-major-open-access-database-to-advance-cancer-research/2016/06/05/8918c442-2b30-11e6-9de3-6e6e7a14000c_story.html?hpid=hp_hp-more-top-stories_biden-810a-stream%3Ahomepage%2Fstory

Side-bar mentioning JNJ and its retained NYC law firm:

http://ih.advfn.com/p.php?pid=nmona&article=71665950

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JNJ News